Company news

In this section you can read not only the latest news of our company. You can also find here: information about past and upcoming events, announcements, press releases and useful links.
28.09.2019
The YOUTH GEMS® line of cosmetics - with peptides and ginseng - is a specially developed programme for comprehensive care for the skin of the face, neck, décolleté and body. The composition of cosmetic products in the series includes unique active ingredients, such as short peptides, which have a targeted tissue-specific effect on all the basic structures of the skin, and ginseng biomass extract characterised by a strong antioxidant and anti-inflammatory effect as well as a number of other active ingredients.
03.08.2019
Vitafoods Asia shapes the food industry for optimal health through science and innovation. Asia's No.1 nutraceutical event connects over 350 international suppliers and 6,000+ business leaders who are looking to source the most innovative and highest quality nutraceutical ingredients, dietary supplements and services.
The values-driven content, insights, consulting and education initiatives ensure attendees gain a global and regional perspective to explore nutraceuticals from every angle; enabling companies to navigate consumer-driven changes further to identify and profit from untapped growth opportunities.
05.07.2019
Huntington's disease (HD) is a fatal, inherited neurodegenerative disorder. The study in functioning and aging of neurons may give an opportunity to regulate these processes. Previous investigations demonstrated the ability of EDR peptide (Glu-Asp-Arg) to penetrate a cell nucleus and stimulate gene expression. The data obtained prompt EDR peptide capability to restore the morphology of spines in striatum neurons in Huntington's disease (HD) mouse model. EDR peptide has been shown by us to bind the DNA in solution (absorption spectroscopy and dynamic light scattering) and in a computer model. The proposed model suggests that EDR peptide binds specific binding site oligo (dCG) along the DNA minor groove.
03.06.2019
Clinical effectivness of Endoluten peptide
The average effectiveness of Endolutene according to clinical and experimental data (endocrinology): 44%. According to clinical and experimental data (cardiology, epithalamin) - 211%.

Efficacy is revealed in patients with physiogenic asthenia and complex diseases after chemical and radiation therapy. The average efficiency in all clinical indicators is 53%. In organotypic cultures of the epiphysis of rats, Endoluten provided a 35% growth of the epiphysis explant zones.
27.04.2019
The congress theme is 'Towards Capability in Ageing – from cell to society'. The theme emphasizes our ability to perform actions in order to reach valued goals within the macro, meso, and micro contexts.

The congress is the natural meeting place for researchers and professionals engaged in various scientific enquires and aging matters; whether in biological science, medical and health sciences, social sciences, in humanities or aging services.

The congress venue will be at the Swedish Exhibition and Congress Centre (Svenska Mässan), located in the city center of Gothenburg.
13.03.2019
International school of gerontology and geriatrics
The VII International School on Gerontology and Geriatrics of the International Institute of Aging, UN-Malta was held in St. Petersburg from April 8 to 13, 2019.

The program of the school includes lectures by leading scientists and specialists in gerontology and geriatrics from Austria, Malta, Great Britain and Russia. The program covers a wide range of issues, including: the demographic aspects of aging, the prospects for aging in the world, the problems of older people in countries with economies in transition, the basic concepts of gerontology, medical and social assistance to the elderly, social status and the role of older people and many others.
18.01.2019
Main focus of the symposium will be on experts' opinion regarding current trends and tendencies in gerontology and anti-aging medicine. World renowned scientific experts will draw up conclusions considering the prospects of the most advanced technologies of today.
The main section of the symposium is aimed to overview evidence-based references and scientific argumentation in favor of means and methods preventing age-related pathology and prolonging sustainable health, as well as to estimate prospects and efficacy of new geroprotectors.